Summary
Direxion Daily Pharmaceutical & Medical Bull 3X ETF is an ETF - a fund traded on an exchange like a stock - run by Direxion. Positions inside: 68. The ten largest make up 265% of the fund.
- Yearly costs
- 1.22%
- Fund size
- $15.0M
- Positions
- 68
- Dividend yield
- 0.44%
- Running since
- 2017
What speaks for it
Nothing stands out in its favour.
What to watch
- The ten largest positions make up 265% of the fund, so its result rests on a few names.
- 100% of the fund is in one sector (Healthcare).
- 82% of the fund is in one country (United States).
- Costs of 1.22% a year are above the middle of comparable funds (0.44%).
- In the last five years its price once dropped by 87% from its high.
- A small fund with $15.0M under management; small funds get closed more often.
- It trades little: only about $855.9K changes hands a day.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- -21%
- 3 months
- -24%
- This year
- +11%
- 1 year
- +60%
- 3 years
- +148%
- 5 years
- -26%
- Avg. market cap
- $61.4B
- P/E
- 15.5x
- Forward P/E
- 11.6x
- P/S
- 2.5x
- P/B
- 3.0x
- P/FCF
- 11.8x
- EV/EBITDA
- 8.7x
- Dividend yield
- 0.73%
- ROIC
- -1.7%
- ROE
- -7.9%
- Gross margin
- 74.6%
- Operating margin
- -146.7%
- Net margin
- -130.5%
- Payout ratio
- 11.4%
- Net debt/EBITDA
- 3.6x
- Beta
- 1.80
Weighted average of the 50 largest companies, which make up 66% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Concentrated- 1 SPSIPH SWAP ASSET LEG (SPSIPHCTL) 113%
- 2 SPSIPH SWAP ASSET LEG (SPSIPHUBL) 57%
- 3 SPSIPH SWAP ASSET LEG (SPSIPHBCL) 30%
- 4 SPSIPH SWAP ASSET LEG (SPSIPHJPL) 29%
- 5 GOLDMAN FINL SQ TRSRY INST 506 23%
- 6 DREYFUS GOVT CASH MAN INS 6.4%
- 7 XEXeris Biopharma Holdings, Inc. XERS 1.9%
- 8 PCPacira BioSciences, Inc. PCRX 1.9%
- 9 MAVeradermics, Incorporated MANE 1.7%
- 10 PRPerrigo PRGO 1.7%
Positions in the fund: 68. The ten largest make up 265% of it.
Composition as of Oct 18, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 100%
By country
- United States 82%
- Ireland 1.5%
- Other countries 16%
By company size
- Mega cap 6.2%
- Large cap 16%
- Mid cap 32%
- Small cap 44%
- Micro cap 1.6%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M. Counted from the companies that make up 71% of the fund.
Largest sector: Healthcare (100%). Largest country: United States (82%). Largest size group: Small cap (44%).
What does it cost me?
Expensive- A year from $10,000
- $122
- Over 20 years
- $5,530
From every $10,000 invested the fund takes $122 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $5,530.
How has it done?
Losing value- A year on average, 5 years
- -5.7%
- Deepest drop
- -87%
- Yearly volatility
- 68%
Average yearly decline over the last five years: 5.7%. Deepest drop in these years: 87% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 0.44%
- Payments a year
- 4
- Last payment
- $0.00
Over the last 12 months it paid $0.06 per share, which is 0.44% of today's price. The last payment was $0.00 on Sep 22, 2026.
Is it easy to buy and sell?
It trades little- Traded a day
- $855.9K
- Shares a day
- 63K
On an average day about $855.9K of the fund changes hands.
How expensive are the companies inside?
Usual valuation- P/E of the companies inside
- 15.5
- Average Bulios Score
- 52 out of 100
Weight by Bulios Fair Price
- Undervalued 35%
- Fairly valued 11%
- Overvalued 54%
On average the companies inside trade for 15.5 times their yearly profit. By Fair Price, 54% of the rated weight comes out as overvalued.
Counted from its largest companies (50), which make up 66% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Similar funds
Funds that hold much of the same. The overlap says how much of their weight they share with this fund.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
XP XPH State Street SPDR S&P Pharmaceuticals ETF | United States | 0.35% | $249.4M | +27% | Pays out | 71% |
IH IHE iShares U.S. Pharmaceuticals ETF | United States | 0.37% | $1.14B | +34% | Pays out | 33% |
PJ PJP Invesco Pharmaceuticals ETF | United States | 0.58% | $361.1M | +30% | Pays out | 27% |